| Loretta Acquaah, | |
|
21 Boston Ct, Newark, NJ 07103-3442 | |
| (917) 302-3067 | |
| Not Available |
| Full Name | Loretta Acquaah |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 21 Boston Ct, Newark, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093595985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SC06130100 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Loretta Acquaah, 21 Boston Ct, Newark, NJ 07103-3442 Ph: (917) 302-3067 | Loretta Acquaah, 21 Boston Ct, Newark, NJ 07103-3442 Ph: (917) 302-3067 |
News Archive
According to scientists, carbon monoxide (CO), a tasteless, colorless and odorless gas, is not only a danger to the environment but also highly toxic to human beings. Found in the exhaust of vehicles and generators, CO has been dubbed the "silent killer" because excessive inhalation is lethal, poisoning the nervous system and heart.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced that they have completed enrollment of a phase II clinical trial of brentuximab vedotin (SGN-35) for relapsed or refractory systemic anaplastic large cell lymphoma.
Sosei Group Corporation confirms the information released today by Novartis that the European Commission has approved Seebri Breezhaler (glycopyrronium bromide) 44 mcg delivered dose (equivalent to 50 mcg glycopyrronium measured dose per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
› Verified 3 days ago
Ruth Viera, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 590 N 7th St, Newark, NJ 07107 Phone: 973-596-5101 Fax: 973-639-5049 | |
Mrs. Nicole Joie Alvarez, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 183 S Orange Ave, Newark, NJ 07103 Phone: 862-201-9127 | |
Ms. Diane M Valente, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 20-22 Madison St, Apt 1, Newark, NJ 07105 Phone: 917-520-8147 | |
Heidi Haiken, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 65 Bergen St, 818, Newark, NJ 07107 Phone: 972-972-0405 | |
Mrs. Sheyla Riaz, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 58 Freeman St, Newark, NJ 07105 Phone: 973-639-6629 | |
Saudi Encarnacion, L.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 58 Freeman St, Newark, NJ 07105 Phone: 973-596-3975 Fax: 973-639-6583 | |
Lauren Nicole Genarelli, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 168 Frontage Rd, Newark, NJ 07114 Phone: 201-669-6846 |